Delivery Order SPE2DB22D3004-SPE2DB25FPL00
Award Date 2/6/25
Potential Completion Date 2/7/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,979.10 and a performance period ending on October 9, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen has been awarded numerous federal contracts by various defense...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has a firm-fixed price, a ceiling value of $1,353.56, and a completion date of June 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML, with a ceiling value of $2,379.26 and a period of performance through June 18, 2025. The contract is a Firm Fixed Price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a firm fixed-price, non-set-aside pricing structure and a ceiling value of $13,179.60. The period of performance extends through May 12, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.50, is for the delivery of the drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a firm fixed price pricing type and a period of performance ending on March 19, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,638.00 and a period of performance through May 7, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.0.5ML, with a ceiling value of $2,457.00 and a period of performance through June 18, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $20,696.16 and a period of performance through December 24, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a medication called WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,228.50 and a period of performance through July 1, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $31,965.93 and a performance period through July 1, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...